Company intelligence / Profile preview

Heuristic Capital Partners

Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

Heuristic Capital Partners is a venture capital firm that specializes in early-stage investments within the "TechBio" and deep tech sectors. The firm focuses on companies that leverage advanced computational methods, artificial intelligence, and engineering to solve complex biological and healthcare challenges. Their portfolio includes high-profile biotechnology startups such as Recursion, PostEra, and Enveda Biosciences. Heuristic Capital Partners typically provides strategic guidance and capital to help bridge the gap between innovative scientific research and commercial application. The firm is known for its focus on platform-based technologies that have the potential to transform drug discovery and development.

Industry: Investors

Beyond the preview

Go deeper on Heuristic Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heuristic Capital Partners.

Explore the full profile